Review of Regulations for General Biologics and Licensing and for Blood Establishments and Blood Products; Extension of Comment Periods

Resumo

The Food and Drug Administration (FDA) is extending to February 13, 1995, the comment periods for two documents published in the Federal Register of June 3, 1994 (59 FR 28821 and 28822, respectively). The documents requested comments on the agency's intent to review certain biological regulations. FDA is taking this action to allow additional opportunity for public comment, including an opportunity to comment at an upcoming public meeting concerning the biologic regulations under review. The comments received will be part of the public record for these two documents.